LHLabcorp
$366.64+46% 1Y
$366.64
$244.6952 weeks$368.11
The business
How LH's business earns
Labcorp earns 8.2% on the capital it employs against an estimated 9.0% cost of capital.
8.2%
Return on invested capital · cost of capital 9.0% · 0.78 points below the estimated cost of capital
- Operating margin
- 10%
Operating margin · Diagnostics & Research median 7.1% · 12 months to Sep 30, 2026
- Cash conversion
- 1.47×
Cash conversion · 1.74× a year ago · operating cash flow divided by operating profit after tax
- Share count, year on year
- −2.5%
Share count, year on year · fewer shares than a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 17% |
| FY2021 | 23% |
| FY2022 | 12% |
| FY2023 | 6.0% |
| FY2024 | 8.3% |
| FY2025 | 9.9% |
Details›
- Gross margin12 months to Sep 30, 2026
- 29%
- Operating margin12 months to Sep 30, 2026
- 10%
- Net margin12 months to Sep 30, 2026
- 6.9%
- Free cash flow margin
- 8.8%
- Revenue, trailing twelve months
- $14.6B
- Free cash flow, trailing twelve months
- $1.29B
- Net income, trailing twelve months
- $1.00B
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 8.2%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Diagnostics & Research
The closest names by size in the same industry